Clinical Trials Browser

Phase 1/2 × OTHER × etaracizumab × Clear all

NCT00027729 2013-06-05

Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer

Phase 1/2 Completed

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms